Pfizer Inflammation News Today

The FINANCIAL -- Pfizer Inc. on November 14 announced that Albert Bourla has been named Chief Operating Officer effective January 1, 2018. The FINANCIAL -- Pfizer Inc. on November 14 announced that Albert Bourla has been named Chief Operating Officer effective January 1, 2018. "The naming of a Chief Operating Officer comes at a time when our business is strong as we continue to advance our strategy while also managing a dynamic and challenging external environment, said » The FINANCIAL Pha...

Press release content from Business Wire. The AP news staff was not involved in its creation.

The best uncensored news, information, and analysis.

Pfizer aims to fund the deal with cash on hand once all regulatory approvals have been obtained.

Pfizer plans to acquire Utah-based Arena Pharmaceuticals for $6.7 billion. Arena Pharmaceuticals is a clinical stage company that develops immunotherapies to treat inflammatory diseases.

Pfizer announced Monday its plans to acquire Utah drugmaker that develops immunotherapies to treat inflammatory diseases.

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for

Press release content from Business Wire. The AP news staff was not involved in its creation.

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.

The best uncensored news, information, and analysis.